Cargando…
Enhanced neprilysin-mediated degradation of hippocampal Aβ42 with a somatostatin peptide that enters the brain
Background: Aggregation of the amyloid-beta (Aβ) peptide is one of the main neuropathological events in Alzheimer's disease (AD). Neprilysin is the major enzyme degrading Aβ, with its activity enhanced by the neuropeptide somatostatin (SST). SST levels are decreased in the brains of AD patients...
Autores principales: | Rofo, Fadi, Ugur Yilmaz, Canan, Metzendorf, Nicole, Gustavsson, Tobias, Beretta, Chiara, Erlandsson, Anna, Sehlin, Dag, Syvänen, Stina, Nilsson, Per, Hultqvist, Greta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738863/ https://www.ncbi.nlm.nih.gov/pubmed/33391505 http://dx.doi.org/10.7150/thno.50263 |
Ejemplares similares
-
Blood–brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer’s disease
por: Rofo, Fadi, et al.
Publicado: (2022) -
A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer’s Disease Mice
por: Rofo, Fadi, et al.
Publicado: (2022) -
Wide-Ranging Effects on the Brain Proteome in a Transgenic
Mouse Model of Alzheimer’s Disease Following Treatment with
a Brain-Targeting Somatostatin Peptide
por: Rofo, Fadi, et al.
Publicado: (2021) -
Novel multivalent design of a monoclonal antibody improves binding strength to soluble aggregates of amyloid beta
por: Rofo, Fadi, et al.
Publicado: (2021) -
Pinpointing Brain TREM2 Levels in Two Mouse Models of Alzheimer’s Disease
por: Meier, Silvio R., et al.
Publicado: (2021)